Category Archives: Cell

Cholesterol accumulates within cells

Cholesterol accumulates within cells

1. atherosclerosis
2. xanthomas
3. inflammation and necrosis (foamy mφ)
4. cholesterolosis
5. Niemann-Pick disease

Robbins Basic Pathology 7th ed, edited by Vinay Kumar, Ramzi S. Cotran, and Stanley J. Robbins, 873 pp, Philadelphia, Pa, Sounders, 2003.

Posted in Cell | Tagged , , , , , , , | Comments Off

Nucleolar organizer regions

Nucleolar organizer regions

-    Correlation between counts of silver-staining NORs (AgNORs) and other cell proliferation indices

-    May not be reliable because counts influenced by variations in ploidy and transcriptional activity

Posted in Cell | Tagged , , , , , , , , | Comments Off

MIB-1

MIB-1

o    Determines proliferative fraction of tumour cell populations

o    Strong immunoreactivity, however allows for recognition of cellular details and therefore better identification of positive cellular subsets

o    No sophisticated technical skill needed to apply technique

o    May have interobserver variability

Posted in Cell | Tagged , , , , , , , , , | Comments Off

Ki-67

Ki-67

o    Expressed in all phases except G0 and early G1; provides a measure of tumour proliferative fraction

o    No sophisticated technical skill needed to apply technique

o    May have interobserver variability

Posted in Cell | Tagged , , , , , , , , , , | Comments Off

Proliferating cell nuclear antigen

Proliferating cell nuclear antigen

PCNA (Proliferating cell nuclear antigen)

o    Expression of PCNA closely related to cell cycle; levels increase during late G1, become maximal during S-phase and decline thereafter

o    Epitope detectability dependent on effects of fixation and processing.

o    PCNA is necessary, but not a sufficient requirement of DNA synthesis and may be expressed by non-cycling cells

Posted in Cell | Tagged , , , , , , , , , | Comments Off

Iododeoxyuridine bromodeoxyuridine labeling

Iododeoxyuridine bromodeoxyuridine labeling

-    Provides cell kinetic information on human tumours (eg. DNA synthesis time, potential tumour doubling time)

-    Immunoperoxidase techniques can be used concurrently to determine proliferation on tumour proliferation heterogeneity at microscopic level

-    Provides averaged values, therefore sacrificing information on tissue spatial distribution of proliferation

Posted in Cell | Tagged , , , , , , , , , | Comments Off

DNA flow cytometry

DNA flow cytometry

-    Has advantage of speed and statistical precision (10, 000-100,000 cells can be analyzed in a few minutes or less)

-    Multiple parameters can be examined

-    Requires expensive apparatus

-    Fresh tissue must be disaggregated which may be difficult; small samples not useful to analyze in this manner since tissue morphology lost through this technique

Posted in Cell | Tagged , , , , , , , | Comments Off

Thymidine labeling

Thymidine labeling

-    Only cells actively synthesizing DNA (ie. in S-phase) will incorporate tritiated thymidine into DNA during pulse labeling; pulse-labelling with tritiated thymidine regarded as functional marker of proliferative activity; reflects fraction of S-phase cells

-    Requires in vivo administration of tritiated thymidine or incubation of fresh tissue in vitro prior to fixation; makes it impractical for clinical use.  Requires autoradiography; time-consuming; not practical.

-    Does not measure duration of S-phase, so it is possible for a tumour to have a slow proliferation rate but a high thymidine labeling index

-    Dependent on tumour sampling

-    Involves cell counting; prone to interobserver variation, reproducibility error and variations in sample size

Posted in Cell | Tagged , , , , , , , , , , , , | Comments Off

Mitotic count

Mitotic count

Most convenient, most widely method used in clinical practice to give first impression of proliferative activity

Defined as number of mitoses/10 HPF

Validity of mitotic count as marker of tumour proliferative activity remains controversial; not standardized, takes no account of cell size; area of single HPF may vary up to 6-fold between different microscopes

Subject to interobserver variation

Posted in Cell | Tagged , , , , , , , , , | Comments Off

Cell Cycle

Cell cycle

The phases of the cell cycle

•    G0

•    G1

•    S

•    G2

•    M

Cyclin Dependent Kinase

•    Cyclin Dependent Kinases allow for the progression of the cell through various phases of the cell cycle by activating cyclin dependent kinases (CDKs)

•    Cyclins are synthesized during certain phases of the cell cycle, phosphorylate constitutively produced CDKs to activate them and their levels subsequently decline

•    Activated CDKs phosphorylate target proteins required for the progression of the cell to the next phase of the cell cycle
c) Desribe the role of RB protein

•    RB prevents the cell from entering S phase until certain cellular signals are met

•    Hypophosphorylated RB is bound to E2F (a transcription factor) and prevents its activity since RB recruits histone deacetylase, causing compaction of chromatin and inhibiting transcription

•    Growth factors cause the concentrations of cyclins D and E to go up, thereby activating cyclin D-CDK4 and cyclin E-CDK2, which then phosphorylate RB

•    Phosphorylation of RB releases it from its complex with E2F, allowing E2F to transcribe key cell cycle proteins such as thymidine kinase, DNA polymerases, cyclin E and dihydrofolate reductase, allowing the cell to transition from G1 to S phase

•    During the M phase, RB is converted to its hypophosphorylated form by cellular phosphatases

Cell Cycle Gene Mutations and Cancer

•    Mutations that activate oncogenes (eg. Her2-neu, EGFR, KIT, BRAF, β-catenin, RAS, MYC, RET, Cyclin D1)

•    Mutations that inactivate tumour suppressor genes (eg. RB, p53, BRCA1, BRCA2, E-cadherin, NF-1, NF-2, APC/ β-catenin, WT-1, p16/INK4)

•    Mutations of DNA repair genes (hMLH1, hMSH2, PMS1, PMS2, ATM)

•    Alterations of genes involved in apoptosis (eg. BCL-2, p53, MYC)

Posted in Cell | Tagged , , , , , , , , | Comments Off